These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33257418)

  • 1. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.
    McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418
    [No Abstract]   [Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covid-19: an economic perspective on vaccinating the world.
    Donaldson C; Biosca O
    BMJ; 2021 Jun; 373():n1498. PubMed ID: 34130993
    [No Abstract]   [Full Text] [Related]  

  • 4. Just allocation of COVID-19 vaccines.
    Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
    Bai AY; Zhang B; Jiang Y; Qiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costs of coronavirus vaccines and their pricing.
    Light DW; Lexchin J
    J R Soc Med; 2021 Nov; 114(11):502-504. PubMed ID: 34732097
    [No Abstract]   [Full Text] [Related]  

  • 8. Future of covid-19 vaccine pricing: lessons from influenza.
    Ramachandran R; Dhodapkar M; Ross JS; Schwartz JL
    BMJ; 2021 Jun; 373():n1467. PubMed ID: 34158283
    [No Abstract]   [Full Text] [Related]  

  • 9. Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
    Hawksbee L; McKee M; King L
    BMJ; 2022 Jan; 376():e067367. PubMed ID: 35101900
    [No Abstract]   [Full Text] [Related]  

  • 10. Profiteering from vaccine inequity: a crime against humanity?
    Hassan F; Yamey G; Abbasi K
    BMJ; 2021 Aug; 374():n2027. PubMed ID: 34400410
    [No Abstract]   [Full Text] [Related]  

  • 11. Africa's vaccines revolution must have research at its core.
    Nature; 2021 Apr; 592(7855):487-488. PubMed ID: 33883739
    [No Abstract]   [Full Text] [Related]  

  • 12. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
    Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
    Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
    [No Abstract]   [Full Text] [Related]  

  • 13. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
    Lie RK; Miller FG
    Milbank Q; 2021 Jun; 99(2):450-466. PubMed ID: 33295679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cash payments in Africa could boost vaccine uptake.
    Arezki R
    Nature; 2021 Aug; 596(7870):9. PubMed ID: 34345045
    [No Abstract]   [Full Text] [Related]  

  • 18. Is there light at the end of the Covid-19 tunnel?
    Mortimer PP
    Rev Med Virol; 2021 May; 31(3):e2173. PubMed ID: 33002254
    [No Abstract]   [Full Text] [Related]  

  • 19. Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers.
    Kartoglu UH; Moore KL; Lloyd JS
    Vaccine; 2020 Jul; 38(34):5393-5395. PubMed ID: 32600910
    [No Abstract]   [Full Text] [Related]  

  • 20. The fight to manufacture COVID vaccines in lower-income countries.
    Maxmen A
    Nature; 2021 Sep; 597(7877):455-457. PubMed ID: 34526695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.